Suppr超能文献

基于社区的中国乳腺癌筛查质量保证目标:模型模拟。

Quality assurance target for community-based breast cancer screening in China: a model simulation.

机构信息

Department of Epidemiology and Health Statistics, School of Public Health, Tianjin Medical University, 22 Qixiangtai Road, Heping District, Tianjin, 300070, People's Republic of China.

Tianjin Binhai New Area Tanggu Center for Disease Control and Prevention, Tianjin, 300451, China.

出版信息

BMC Cancer. 2018 Mar 7;18(1):261. doi: 10.1186/s12885-018-4168-1.

Abstract

BACKGROUND

We aimed to clarify the feasibility of a community-based screening strategy for breast cancer in Tianjin, China; to identify the factors that most significantly influenced its feasibility; and to identify the reference range for quality control.

METHODS

A state-transition Markov model simulated a hypothetical cohort of 100,000 healthy women, the start aged was set at 35 years and the time horizon was set to 50 years. The primary outcome for the model was the incremental cost-utility ratio (ICUR), defined as the program's cost per quality-adjusted life year (QALY) gained. Three screening strategies providing by community health service for women aged 35 to 69 years was compared regarding to different intervals.

RESULT

The probability of the ICUR being below 20 272USD (i.e., triple the annual gross domestic product [3 GDPs]) per QALY saved was 100% for annual screening strategy and screening every three years. Only when the attendance rate was > 50%, the probability for annual screening would be cost effective > 95%. The probability for the annual screening strategy being cost effective could reach to 95% for a willingness-to-pay (WTP) of 2 GDPs when the compliance rate for transfer was > 80%. When 10% stage I tumors were detected by screening, the probability of the annual screening strategy being cost effective would be up to 95% for a WTP > 3 GDPs.

CONCLUSION

Annual community-based breast cancer screening was cost effective for a WTP of 3 GDP based on the incidence of breast cancer in Tianjin, China. Measures are needed to ensure performance indicators to a desirable level for the cost-effectiveness of breast cancer screening.

摘要

背景

本研究旨在明确中国天津市基于社区的乳腺癌筛查策略的可行性;确定影响其可行性的最重要因素;并确定质量控制的参考范围。

方法

采用状态转移马尔可夫模型模拟了一个由 10 万名健康女性组成的假设队列,起始年龄为 35 岁,时间范围为 50 年。模型的主要结果是增量成本效益比(ICUR),定义为该项目每获得一个质量调整生命年(QALY)的成本。对 35 至 69 岁女性的三种社区卫生服务提供的筛查策略,根据不同的间隔进行了比较。

结果

在节省每 QALY 成本 20272 美元(即三倍年国内生产总值[3GDP])的情况下,年度筛查策略和每三年筛查一次的 ICUR 低于该值的概率为 100%。只有当出勤率>50%时,年度筛查才具有成本效益>95%。当转移符合率>80%时,年度筛查策略的成本效益比为 2GDP 时,其具有成本效益的概率可达到 95%。当通过筛查检测到 10%的 I 期肿瘤时,年度筛查策略的成本效益比为 3GDP 时,其具有成本效益的概率可达到 95%。

结论

基于天津市乳腺癌的发病率,年度基于社区的乳腺癌筛查对于支付意愿(WTP)为 3GDP 是具有成本效益的。需要采取措施确保绩效指标达到理想水平,以实现乳腺癌筛查的成本效益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/478f/5840933/59c2c8d1459d/12885_2018_4168_Fig1_HTML.jpg

相似文献

1
2
Cost-effectiveness of risk-based breast cancer screening programme, China.
Bull World Health Organ. 2018 Aug 1;96(8):568-577. doi: 10.2471/BLT.18.207944. Epub 2018 Jun 28.
3
Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
J Med Screen. 2014 Dec;21(4):180-8. doi: 10.1177/0969141314549758. Epub 2014 Sep 3.
4
High-resolution microendoscopy for esophageal cancer screening in China: A cost-effectiveness analysis.
World J Gastroenterol. 2015 May 14;21(18):5513-23. doi: 10.3748/wjg.v21.i18.5513.
5
[Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai].
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Dec 10;38(12):1665-1671. doi: 10.3760/cma.j.issn.0254-6450.2017.12.017.
6
Cost-Effectiveness Analysis of Digital Breast Tomosynthesis and Mammography in Breast Cancer Screening: A Markov Modeling Study.
J Epidemiol Glob Health. 2024 Sep;14(3):933-946. doi: 10.1007/s44197-024-00239-z. Epub 2024 May 15.
7
Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women.
Value Health. 2019 Feb;22(2):185-193. doi: 10.1016/j.jval.2018.07.880. Epub 2018 Sep 8.
8
Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China.
Clin Ther. 2011 Oct;33(10):1446-55. doi: 10.1016/j.clinthera.2011.09.016. Epub 2011 Oct 11.
9
The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria.
Value Health. 2017 Sep;20(8):1048-1057. doi: 10.1016/j.jval.2017.04.009. Epub 2017 May 16.
10
Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
J Clin Oncol. 2012 May 1;30(13):1468-75. doi: 10.1200/JCO.2011.38.7001. Epub 2012 Feb 27.

本文引用的文献

1
Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment.
Ont Health Technol Assess Ser. 2016 Jul 1;16(15):1-71. eCollection 2016.
2
[Discussion of breast cancer screening model in China].
Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Jul;37(7):1039-43. doi: 10.3760/cma.j.issn.0254-6450.2016.07.026.
3
The relationship between cancer detection in mammography and image quality measurements.
Phys Med. 2016 Apr;32(4):568-74. doi: 10.1016/j.ejmp.2016.03.004. Epub 2016 Apr 6.
4
Characteristics of breast cancer in Central China, literature review and comparison with USA.
Breast. 2016 Dec;30:208-213. doi: 10.1016/j.breast.2016.01.004. Epub 2016 Mar 23.
5
Impact of Changes to Breast Cancer Screening Guidelines on Healthcare Providers and Patients.
Clin J Oncol Nurs. 2016 Apr;20(2):203-5. doi: 10.1188/16.CJON.203-205.
6
Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.
CA Cancer J Clin. 2016 Jan-Feb;66(1):31-42. doi: 10.3322/caac.21320. Epub 2015 Oct 29.
7
Benefits and Harms of Breast Cancer Screening: A Systematic Review.
JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验